Insider trades
RedCo II Master Fund, Director of Fate Therapeutics FATE, has filed 8 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $19.6M. The latest trade was on 04/20.
RedCo II Master Fund
Director
- Company
- Fate Therapeutics FATE
- First filing
- 23/03/13
- Trades
- 72 trades
- Buys / sales
- 8 / 7
- 12-month net buying
- −$19.6M
- Last trade
- 04/20
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ADCT | Open-market sale | 03/31–04/02 | 04/02 | 5,880,415 sh6 trades | $3.34avg. | $19,641,066.76 | No record |
ADCT | Open-market buy | 24/12/11 | 24/12/13 | 200,000 sh4 trades | $3.05avg. | $609,000 | No record |
ADC TherapeuticsADCT | Open-market sale | 24/12/04 | 24/12/06 | 25,352 sh | $2.07 | $52,478.64 | −0.2% |
ADCT | Open-market buy | 24/07/01 | 24/07/03 | 800,000 sh2 trades | $2.81avg. | $2,248,000 | No record |
| Open-market buy | 23/11/20 | 23/11/22 | 1,500,000 sh2 trades | $4.00avg. | $6,000,000 | No record |
